Abstract:Objective. The human lipidomic profile reflects lipid metabolism, including the early phase of pathophysiological changes associated with diseases. An investigation of the association between the plasma lipidomic profile and adolescent obesity might provide new insights into the biological mechanisms of obesity. Therefore, we aimed to investigate the association of the plasma lipidome with obesity in Chinese adolescents using lipidomics. Methods. Using a combination of liquid chromatography and electrospray ionization tandem mass spectrometry, we quantified 328 lipid species from 24 lipid classes and subclasses in 100 male adolescents aged 14–16 years who were categorized into four groups: (1) normal weight with traditional normal clinical plasma lipid levels (NN); (2) normal weight with traditional abnormal clinical plasma lipid levels (NA); (3) obese with traditional normal clinical plasma lipid levels (ON); and (4) obese with traditional abnormal clinical plasma lipid levels (OA). The concentrations of all the lipid species were compared between obese and normal-weight adolescents at different traditional clinical plasma lipid levels using the Kruskal–Wallis test followed by the Mann–Whitney U test. A partial least squares discriminant analysis (PLS-DA) was applied to select lipids with a significant ability to discriminate adolescent obesity. Results. The lipidomic profile distinguished obese adolescents from normal-weight subjects. Regardless of whether traditional clinical plasma lipid levels were normal or abnormal, we observed a significant reduction in the levels of five lysophosphatidylcholines (LPC) species (LPC18:2, LPC18:1, LPC20:2, LPC20:1, and LPC20:0) in the obese group compared with the normal-weight group (difference = −31.29% to −13.19%; P=9.91×10−5 to 2.28×10−2). The ability of these five LPC species to discriminate adolescent obesity was confirmed in the PLS-DA model. Conclusions. The findings provided evidence for the association of some LPC species with adolescent obesity. The discriminatory effects of five LPC species were identified between normal-weight and obese adolescents, independent of traditional clinical plasma lipid levels. These results will provide a basis for validation in subsequent studies.

Lipidomic perturbations of normal-weight adiposity phenotypes and their mediations on diet-adiposity associations

Positive Relationship Between Serum Low-Density Lipoprotein Cholesterol Levels and Visceral Fat in a Chinese Nondiabetic Population.

Adiposity, Metabolomic Biomarkers, and Risk of Nonalcoholic Fatty Liver Disease: a Case-Cohort Study

Distinct metabolite profiles of adiposity indices and their relationships with habitual diet in young adults

Association of dietary patterns, circulating lipid profile, and risk of obesity

Proteo-genomic analyses in relatively lean Chinese adults identify proteins and pathways that affect general and central adiposity levels

Individual SFA Intake and Risk of Overweight/obesity: Findings from a Population-Based Nationwide Cohort Study

Conventional and genetic associations of adiposity with 1463 proteins in relatively lean Chinese adults

The association between body composition and metabolically unhealthy profile of adults with normal weight in Northwest China

A Lipid Signature with Perturbed Triacylglycerol Co-Regulation, Identified from Targeted Lipidomics, Predicts Risk for Type 2 Diabetes and Mediates the Risk from Adiposity in Two Prospective Cohorts of Chinese Adults.

Lipidomic Profile Revealed the Association of Plasma Lysophosphatidylcholines with Adolescent Obesity

Adiposity and NMR-measured lipid and metabolic biomarkers among 30,000 Mexican adults

Normal Body Weight with Central Obesity Increases Newly Onset Cardiovascular Disease in Adults from Rural Northeast China

Association between obesity indicators and cardiometabolic disease in Chinese adults

Association of major dietary patterns and different obesity phenotypes in Southwest China: the China Multi-Ethnic Cohort (CMEC) Study

The effects of weight loss and improved metabolic health status on the risk of non-alcoholic fatty liver disease-results from a prospective cohort in China

Abdominal obesity-related lipid metabolites may mediate the association between obesity and glucose dysregulation

Distinct Changes in Serum Metabolites and Lipid Species in the Onset and Progression of NAFLD in Obese Chinese

2074-LB: Metabolic Heterogeneity of Adipocytes during Obesity Revealed by Single Nucleus RNA-seq

Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes

Association between weight change, waist circumference change, and the risk of nonalcoholic fatty liver disease in individuals with metabolically healthy overweight or obesity and metabolically unhealthy overweight or obesity